BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 20431066)

  • 41. HDL scavenger receptor class B type I and platelet function.
    Nofer JR; van Eck M
    Curr Opin Lipidol; 2011 Aug; 22(4):277-82. PubMed ID: 21537173
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human CETP aggravates atherosclerosis by increasing VLDL-cholesterol rather than by decreasing HDL-cholesterol in APOE*3-Leiden mice.
    de Vries-van der Weij J; Zadelaar S; Toet K; Havekes LM; Kooistra T; Rensen PC
    Atherosclerosis; 2009 Sep; 206(1):153-8. PubMed ID: 19345354
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diet-induced dyslipidemia impairs reverse cholesterol transport in hamsters.
    Tréguier M; Briand F; Boubacar A; André A; Magot T; Nguyen P; Krempf M; Sulpice T; Ouguerram K
    Eur J Clin Invest; 2011 Sep; 41(9):921-8. PubMed ID: 21299553
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Urokinase-type plasminogen activator (uPA) decreases hepatic SR-BI expression and impairs HDL-mediated reverse cholesterol transport.
    Chulsky S; Paland N; Lazarovich A; Fuhrman B
    Atherosclerosis; 2014 Mar; 233(1):11-8. PubMed ID: 24529115
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Re-evaluation of cholesteryl ester transfer protein function in atherosclerosis based upon genetics and pharmacological manipulation.
    Yamashita S; Matsuzawa Y
    Curr Opin Lipidol; 2016 Oct; 27(5):459-72. PubMed ID: 27454452
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Endothelial Expression of Scavenger Receptor Class B, Type I Protects against Development of Atherosclerosis in Mice.
    Vaisman BL; Vishnyakova TG; Freeman LA; Amar MJ; Demosky SJ; Liu C; Stonik JA; Sampson ML; Pryor M; Bocharov AV; Eggerman TL; Patterson AP; Remaley AT
    Biomed Res Int; 2015; 2015():607120. PubMed ID: 26504816
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The high-fat high-fructose hamster as an animal model for niacin's biological activities in humans.
    Connolly BA; O'Connell DP; Lamon-Fava S; LeBlanc DF; Kuang YL; Schaefer EJ; Coppage AL; Benedict CR; Kiritsy CP; Bachovchin WW
    Metabolism; 2013 Dec; 62(12):1840-9. PubMed ID: 24035454
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased plasma levels of LDL cholesterol in rabbits after adenoviral overexpression of human scavenger receptor class B type I.
    Tancevski I; Frank S; Massoner P; Stanzl U; Schgoer W; Wehinger A; Fievet C; Eller P; Patsch JR; Ritsch A
    J Mol Med (Berl); 2005 Nov; 83(11):927-32. PubMed ID: 16133421
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of hepatic scavenger receptor-class B type I by RNA interference decreases atherosclerosis in rabbits.
    Demetz E; Tancevski I; Duwensee K; Stanzl U; Huber E; Heim C; Handle F; Theurl M; Schroll A; Tailleux A; Dietrich H; Patsch JR; Eller P; Ritsch A
    Atherosclerosis; 2012 Jun; 222(2):360-6. PubMed ID: 22494625
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thrombocytopenia and platelet abnormalities in high-density lipoprotein receptor-deficient mice.
    Dole VS; Matuskova J; Vasile E; Yesilaltay A; Bergmeier W; Bernimoulin M; Wagner DD; Krieger M
    Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1111-6. PubMed ID: 18436807
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Advances on the research of the relationship between cholesteryl ester transfer protein and atherosclerosis].
    Huang ZY; Guo HW
    Wei Sheng Yan Jiu; 2005 Nov; 34(6):765-7. PubMed ID: 16535859
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CETP expression enhances liver HDL-cholesteryl ester uptake but does not alter VLDL and biliary lipid secretion.
    Harada LM; Amigo L; Cazita PM; Salerno AG; Rigotti AA; Quintão EC; Oliveira HC
    Atherosclerosis; 2007 Apr; 191(2):313-8. PubMed ID: 16806230
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Aspirin regulates expression and function of scavenger receptor-BI in macrophages: studies in primary human macrophages and in mice.
    Tancevski I; Wehinger A; Schgoer W; Eller P; Cuzzocrea S; Foeger B; Patsch JR; Ritsch A
    FASEB J; 2006 Jul; 20(9):1328-35. PubMed ID: 16816107
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human scavenger receptor class B type I is expressed with cell-specific fashion in both initial and terminal site of reverse cholesterol transport.
    Nakagawa-Toyama Y; Hirano K; Tsujii K; Nishida M; Miyagawa J; Sakai N; Yamashita S
    Atherosclerosis; 2005 Nov; 183(1):75-83. PubMed ID: 15970294
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Spontaneous and diet-aggravated hemolysis and its correction by probucol in SR-BI knockout mice with LDL-R deficiency.
    Liao J; Gao M; Wang M; Guo X; Huang W; Liu G
    Biochem Biophys Res Commun; 2015 Jul 17-24; 463(1-2):48-53. PubMed ID: 25983325
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Scavenger receptor BI facilitates the metabolism of VLDL lipoproteins in vivo.
    Van Eck M; Hoekstra M; Out R; Bos IS; Kruijt JK; Hildebrand RB; Van Berkel TJ
    J Lipid Res; 2008 Jan; 49(1):136-46. PubMed ID: 17954936
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cholesteryl ester transfer protein corrects dysfunctional high density lipoproteins and reduces aortic atherosclerosis in lecithin cholesterol acyltransferase transgenic mice.
    Föger B; Chase M; Amar MJ; Vaisman BL; Shamburek RD; Paigen B; Fruchart-Najib J; Paiz JA; Koch CA; Hoyt RF; Brewer HB; Santamarina-Fojo S
    J Biol Chem; 1999 Dec; 274(52):36912-20. PubMed ID: 10601244
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Developmental abnormalities in mouse embryos lacking the HDL receptor SR-BI.
    Santander NG; Contreras-Duarte S; Awad MF; Lizama C; Passalacqua I; Rigotti A; Busso D
    Hum Mol Genet; 2013 Mar; 22(6):1086-96. PubMed ID: 23221804
    [TBL] [Abstract][Full Text] [Related]  

  • 59. HDL cholesterol levels are an important factor for determining the lifespan of erythrocytes.
    Meurs I; Hoekstra M; van Wanrooij EJ; Hildebrand RB; Kuiper J; Kuipers F; Hardeman MR; Van Berkel TJ; Van Eck M
    Exp Hematol; 2005 Nov; 33(11):1309-19. PubMed ID: 16263415
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Carboxy-terminal deletion of the HDL receptor reduces receptor levels in liver and steroidogenic tissues, induces hypercholesterolemia, and causes fatal heart disease.
    Pal R; Ke Q; Pihan GA; Yesilaltay A; Penman ML; Wang L; Chitraju C; Kang PM; Krieger M; Kocher O
    Am J Physiol Heart Circ Physiol; 2016 Dec; 311(6):H1392-H1408. PubMed ID: 27694217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.